Billionaire Profile
Cai Hongbin
Global Rank
#2933

Image: Public domain | via Wikimedia Commons

Cai Hongbin

CEO, Jiangsu Hengrui Medicine
CN
Real-Time Net Worth
$1B
As of December 2025
Age
0
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Cai Hongbin is a Chinese billionaire whose wealth stems from his significant stake in Jiangsu Hengrui Medicine, one of China's largest pharmaceutical companies. He is ranked #2933 on Forbes' 2025 Billionaires list with a net worth of $1.0 billion. Cai's career includes academic roles as Dean of the HKU Business School and former Dean of Guanghua School of Management at Peking University. Cai's success reflects the burgeoning pharmaceutical industry in China.

Wealth Over Time

In-Depth Profile

Early Life and Education

Cai Hongbin's academic journey began with a Bachelor's degree in Mathematics from Wuhan University in 1988. He continued his education, earning a Master's in Economics from Peking University in 1991, and a Ph.D. in Economics from Stanford University in 1997. These educational experiences laid the groundwork for his future career in academia and business.

Rise to Success

Cai's primary source of wealth is his stake in Jiangsu Hengrui Medicine, a leading pharmaceutical company in China. Jiangsu Hengrui is known for its significant contributions to the pharmaceutical industry, with a focus on innovation and development. Cai's investment in this sector has been a key factor in his rise to billionaire status.

Career and Academic Achievements

Beyond his financial success, Cai Hongbin has had a distinguished career in academia. From 1997 to 2005, he taught at the University of California, Los Angeles. He then served as Dean of Guanghua School of Management at Peking University from December 2010 to January 2017. Since June 2017, he has been the Dean of the HKU Business School, further cementing his reputation as a leader in the field of economics and business education. He was elected as a Fellow of the Econometric Society.

Key Business Strategies and Leadership

While specific business strategies related to his holdings are not readily available, Cai's success is linked to the growth of Jiangsu Hengrui, which employs over 20,000 people. The pharmaceutical industry in China has experienced rapid growth, making it the second-largest in the world. Cai's foresight in investing in this sector has positioned him well.

Philanthropy

Details regarding Cai Hongbin’s specific philanthropic endeavors are not available.

Career Milestones

1997

University of California, Los Angeles

Taught at the University of California, Los Angeles.

2005

Dean of Guanghua School of Management, Peking University

Served as Dean of Guanghua School of Management, Peking University.

2017

Dean of HKU Business School

Joined the HKU Business School and serves as the Dean.